Skip to content

Follow up study on safety and performance of distal humerus plate system

A Prospective, Single Arm, Post Market Clinical Follow-up (PMCF) Study to Evaluate the Safety and Performance of Distal Humerus Plate System Intended for Fracture Fixation - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078482
Enrollment
20
Registered
2024-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S424- Fracture of lower end of humerus

Interventions

Intervention1: Distal humerus plate system: Intervention is intended to provide fixation of distal humerus fracture. The enrolled patients will be followed up at various time points till one year of s

Sponsors

Auxein Medical Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting to Orthopaedic emergency/OPD with distal humerus fractures/ intercondylar humerus fracture.

Exclusion criteria

Exclusion criteria: 1. Infection, local or systemic, acute or chronic inflammation at the operative site. 2. Patient with known history of metal allergy. 3. Mental illness or schizophrenic, which may cause patients to ignore the limitations and precautions of the implanted material leading to implants fracture and complication. 4. Patients having inadequate tissue coverage over the operative site. 5. Presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor ?like condition of the bone which may compromise fixation. 6. Female participant who is pregnant or planning pregnancy during the course of the study. 7. Chronic alcoholics, and smokers. 8. Any condition or anatomy that makes treatment with the distal humerus plate system infeasible. 9. Patients who are incarcerated or have pending incarceration.

Design outcomes

Primary

MeasureTime frame
1. Evaluation of function outcome scores (MEPS and Quick DASH). 2. Improvement in pain score (VAS).Timepoint: Three time points; 3, 6, and 12 months.

Secondary

MeasureTime frame
1. Radiological evaluation by X-ray radiographs to assess the mean time taken to achieve bone union. 2. Evaluation of any complications/adverse events associated with implants.Timepoint: Three time points; 3, 6, and 12 months.

Countries

India

Contacts

Public ContactMr Gaurav Luthra

Auxein Medical Private Limited

clinical2@auxeinmedical.com7419660141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026